CATALOGO DEI PRODOTTI DELLA RICERCA

LAWLOR, Rita Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.021
NA - Nord America 9.479
AS - Asia 7.703
SA - Sud America 1.321
AF - Africa 342
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 4
Totale 28.930
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.201
RU - Federazione Russa 4.069
SG - Singapore 2.987
CN - Cina 2.069
IT - Italia 1.625
GB - Regno Unito 1.477
BR - Brasile 1.054
HK - Hong Kong 802
VN - Vietnam 740
DE - Germania 600
IE - Irlanda 474
SE - Svezia 421
FR - Francia 409
KR - Corea 247
FI - Finlandia 243
NL - Olanda 165
IN - India 161
CA - Canada 142
JP - Giappone 94
UA - Ucraina 90
MX - Messico 88
ES - Italia 86
AR - Argentina 84
AT - Austria 81
BD - Bangladesh 78
TR - Turchia 73
ID - Indonesia 71
ZA - Sudafrica 60
NG - Nigeria 58
PL - Polonia 58
AU - Australia 52
IQ - Iraq 52
JO - Giordania 52
TG - Togo 50
EC - Ecuador 46
PK - Pakistan 43
BE - Belgio 42
VE - Venezuela 37
CO - Colombia 33
BJ - Benin 32
SA - Arabia Saudita 31
MA - Marocco 30
UZ - Uzbekistan 30
KE - Kenya 27
CL - Cile 24
IR - Iran 23
LT - Lituania 22
CH - Svizzera 20
PY - Paraguay 20
CZ - Repubblica Ceca 19
PH - Filippine 17
BF - Burkina Faso 15
EG - Egitto 15
MY - Malesia 15
TN - Tunisia 15
ET - Etiopia 13
AZ - Azerbaigian 11
IL - Israele 11
KG - Kirghizistan 11
BG - Bulgaria 10
LV - Lettonia 10
NP - Nepal 10
PT - Portogallo 10
GR - Grecia 9
HR - Croazia 9
OM - Oman 9
RS - Serbia 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
RO - Romania 8
SK - Slovacchia (Repubblica Slovacca) 8
AM - Armenia 7
BO - Bolivia 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
PA - Panama 7
PE - Perù 7
TH - Thailandia 7
TW - Taiwan 7
UY - Uruguay 7
AL - Albania 6
HN - Honduras 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
SI - Slovenia 6
LB - Libano 5
MD - Moldavia 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
CY - Cipro 4
HU - Ungheria 4
JM - Giamaica 4
LU - Lussemburgo 4
NI - Nicaragua 4
NO - Norvegia 4
PS - Palestinian Territory 4
UG - Uganda 4
AD - Andorra 3
BN - Brunei Darussalam 3
EE - Estonia 3
Totale 28.876
Salva come PNG Salva come JPEG
Città #
Singapore 1.604
Moscow 1.403
Ashburn 1.260
Southend 1.154
Dallas 1.022
San Jose 1.007
Chandler 945
Verona 823
Hong Kong 785
Beijing 437
Dublin 434
The Dalles 423
New York 295
Jacksonville 250
Ann Arbor 213
Ho Chi Minh City 197
Los Angeles 188
Woodbridge 182
Munich 175
Council Bluffs 167
Hanoi 144
Lawrence 134
Princeton 134
Wilmington 130
Jinan 123
Houston 116
São Paulo 107
Santa Clara 100
Redondo Beach 99
Buffalo 94
Nanjing 93
Helsinki 89
Shenyang 88
Redmond 87
Dong Ket 82
Columbus 81
London 75
Tokyo 71
Nuremberg 66
Sindelfingen 66
Hebei 65
Orem 60
Zhengzhou 59
Milan 58
Seattle 54
Abuja 52
Tianjin 52
Lomé 50
Turku 50
Amman 49
Montreal 49
Vienna 47
Frankfurt am Main 46
Warsaw 46
Amsterdam 44
Guangzhou 44
Brussels 42
Jakarta 41
Lappeenranta 41
Haikou 40
Stockholm 40
Changsha 39
Johannesburg 39
Hangzhou 38
Madrid 38
Ningbo 38
Nanchang 36
Poplar 36
Haiphong 35
Washington 35
Brooklyn 34
Taizhou 34
Denver 33
Phoenix 33
Rio de Janeiro 33
Toronto 33
Chennai 32
Cotonou 32
Jiaxing 32
Seoul 31
Falkenstein 30
Mexico City 30
Redwood City 30
Taiyuan 30
Brescia 29
Da Nang 29
Chicago 28
Manchester 28
Dearborn 27
Bologna 26
Tashkent 26
Ankara 25
Belo Horizonte 25
Rome 25
Shanghai 25
Curitiba 24
San Francisco 24
Boston 23
Sydney 23
Atlanta 22
Totale 17.162
Salva come PNG Salva come JPEG
Nome #
Common Minimum Technical Standards and Protocols for Biobanks Dedicated to Cancer Research 564
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 291
Whole-genome landscape of pancreatic neuroendocrine tumours 280
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 276
Genomic characterization of hepatoid tumors: context matters 260
1177PUndiscovered immune heterogeneity in pancreatic adenocarcinoma (PDAC) 251
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 251
Genomic analyses identify molecular subtypes of pancreatic cancer 251
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 244
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 238
Gα15 in early onset of pancreatic ductal adenocarcinoma 232
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. 229
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 226
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 223
A multimodality test to guide the management of patients with a pancreatic cyst 217
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 215
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 214
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 213
RON is not a prognostic marker for resectable pancreatic cancer 209
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 203
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 203
428OImmune landscape of pancreatic neuroendocrine tumours (PanNETs) 201
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer 200
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation 200
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 197
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 196
Ampulla of Vater carcinoma: Molecular landscape and clinical implications 196
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients 195
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk 193
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 193
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 192
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 192
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 190
Reporting tumor molecular heterogeneity in histopathological diagnosis 190
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 188
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer 188
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 187
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 187
Lost in translation: returning germline genetic results in genome-scale cancer research 186
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation 186
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 184
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 183
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 183
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer 183
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 183
Comparative Lesions Analysis Through a Targeted Sequencing Approach 182
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 181
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 179
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 179
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 177
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 176
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 175
Hypermutation In Pancreatic Cancer 174
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 171
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 171
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 171
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns 170
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study 170
Divergent mutational processes distinguish hypoxic and normoxic tumours 169
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 168
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan 168
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 167
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 166
Sex differences in oncogenic mutational processes 166
Splice variants as novel targets in pancreatic ductal adenocarcinoma 165
Loss of FGFR4 promotes the malignant phenotype of PDAC 164
Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids 164
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 163
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 161
Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma 161
Genome-wide association study identifies an early onset pancreatic cancer risk locus 160
Exosomal miRNA signatures of pancreatic lesions 160
Author Correction: The landscape of viral associations in human cancers 159
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 158
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 158
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 157
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 156
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 155
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer 153
A Model of Collaboration ad Experiences between Bio-industry and Academic Biobanks 153
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 153
International network of cancer genome projects 152
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 152
Research capacity. Enabling the genomic revolution in Africa 151
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations 151
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 151
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 150
Pan-cancer analysis of whole genomes 150
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 150
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 149
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 149
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 148
Biosampling and biobanking (Chapter7) 148
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium 147
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 147
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 147
Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission 145
Long-term organoid culture of a small intestinal neuroendocrine tumor 145
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes 144
Urine Metabolic Signature of Pancreatic Ductal Adenocarcinoma by (1)H Nuclear Magnetic Resonance: Identification, Mapping, and Evolution 144
Totale 18.663
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.985
article - articoli 90.024
book - libri 1.145
conference - conferenze 1.273
curatela - curatele 0
other - altro 1.104
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.439
Totale 189.970
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021287 0 0 0 0 0 0 0 0 0 45 90 152
2021/20221.318 127 354 75 114 52 33 54 90 51 32 81 255
2022/20232.624 160 320 203 439 219 619 45 165 291 35 89 39
2023/20241.877 57 124 125 168 177 330 95 192 56 129 305 119
2024/20255.563 298 285 329 815 309 299 429 340 704 346 522 887
2025/202614.117 1.058 735 1.147 2.330 3.522 957 1.336 873 1.319 840 0 0
Totale 29.434